Floatz logo

TANCIN

Stage 0 Pancreatic Cancer American Joint Committee on Cancer v8

OHSU Knight Cancer InstituteSmall moleculePhase 2Active
CCC
50/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
35/ 100
Competitive Position
95/ 100

Competitive context

381 Active assets in the Stage 0 Pancreatic Cancer American Joint Committee on Cancer v8 cohort.

Asset / SponsorPhaseRating
Tinzaparin
Helsinki University Central Hospital
Phase 4BBB
FLUOROURACILUM
Memorial Sloan Kettering Cancer Center
Phase 3BB
Eloxatin
Memorial Sloan Kettering Cancer Center
Phase 3BB
CIS-DIAMMINEDICHLOROPLATINUM II
Taiho Oncology, Inc.
Phase 3BB
Irinotecan
Memorial Sloan Kettering Cancer Center
Phase 3BB

View all 50 →

Same molecule, other indications

TANCIN is also rated in:

hypertensive disorderDormant
BB
Indicative ·
65 / 100
View asset →
Metabolic DisorderDormant
B
Indicative ·
56 / 100
View asset →
Metabolic SyndromeDormant
B
Indicative ·
56 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →